Free Newsletter

FierceVaccines is a weekly update on the vaccine industry, with a special focus on the innovations revolutionizing the development and production of vaccines. Join thousands of lab research professionals who get FierceVaccines via weekly email. Sign up today!

About | View Sample | Privacy

Hottest Products

Compare Top Solutions in:

Evaluate more than 400,000 products >>

Featured Jobs

Clinical Research Coordinator
Lovelace Respiratory Research Institute - Albuquerque, NM
Manager, Strategic Forecasting & Analytics Job
Celgene Corporation - Basking Ridge, NJ, US
Partner
Lundbeckfond Ventures - Copenhagen, Denmark
Patient Support Specialist Job
Celgene Corporation - Berkeley Heights, NJ, US
Clinical Trials Site Director
Lovelace Respiratory Research Institute - Albuquerque, NM

More Jobs >>

Events

Biomarker Applications for Improved Clinical Trial Outcomes
Nov. 15-16 — Boston
New Paradigms to Fund & Move Biotech
January 11-12, 2012 — San Francisco, CA
Pharmacovigilance and Risk Management Strategies 2012
January 22-25, 2012 — Arlington, Virginia
Life Science in the Cloud
Nov 16, 2011 — Cambridge, MA

More Events >>

Related Tags >> Dengue fever NIAID PharmaJet International Vaccines Institute

Inviragen News

Most Popular Inviragen Story

Inviragen, PharmaJet land $15.5M for needle-free dengue vax

October 8, 2010 — 8:58am ET | By Erica Teichert

The National Institute of Allergy and Infectious Diseases awarded a five-year, $15.5 million contract to Inviragen and PharmaJet to continue their work on a needle-free dengue vaccine. The disease, Read more...

Inviragen Press Releases

Inviragen and University of Texas Medical Branch Receive Funding for Development of a Novel Recombinant Chikungunya Virus Vaccin
International Vaccine Institute and Inviragen announce a collaboration to accelerate development of a dengue vaccine
International Vaccine Institute and Inviragen Announce a Collaboration to Accelerate Development of a Dengue Vaccine
Inviragen and Duke-NUS Form Collaborative Vaccine Research and Development Program
Inviragen Initiates DENVax Phase 1 Clinical Testing in Colombia

Latest Headlines

Inviragen, U of Texas land $3M grant for chikungunya vaccine
August 17, 2011
Inviragen forms dengue partnership with IVI
August 4, 2011
Inviragen starts Colombian Phase I dengue trial
October 25, 2010
Inviragen, PharmaJet land $15.5M for needle-free dengue vax
October 8, 2010

Paid Research Reports

Trends in mHealth and Telemedicine
The Global Aesthetic Dermatology Market Outlook
Future Directions in Regenerative Medicine
Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline

More Research Reports >>

THE FIERCEMARKETS NETWORK